These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9302457)

  • 21. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent-low dose G-CSF treatment in a patient with chronic neutropenia.
    Yetgin S; Ozbek N
    Turk J Pediatr; 1998; 40(3):421-4. PubMed ID: 9763907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome?
    Dereure O; Hillaire-Buys D; Guilhou JJ
    Br J Dermatol; 2004 Jun; 150(6):1228-30. PubMed ID: 15214930
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug updates.
    J Am Pharm Assoc (Wash); 1996 Jan; NS36(1):7-8. PubMed ID: 8835435
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
    Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S
    Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disseminated vascular papules in an immunodeficient patient being treated with granulocyte colony-stimulating factor.
    Lenczowski JM; Cassarino DS; Jain A; Turner ML
    J Am Acad Dermatol; 2003 Jul; 49(1):105-8. PubMed ID: 12833018
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor.
    Thompson MA; Dyson SW; Faderl S
    Am J Hematol; 2006 Sep; 81(9):703-5. PubMed ID: 16838322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
    J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIDS. The exorcists.
    Gorman C
    Time; 1996; 148(14):64-6. PubMed ID: 10161476
    [No Abstract]   [Full Text] [Related]  

  • 32. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH
    Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential for immune reconstitution through G-CSF treatment of HIV patients.
    Von Aulock S; Hartung T
    Arch Immunol Ther Exp (Warsz); 2002; 50(2):111-20. PubMed ID: 12022700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is granulocyte colony-stimulating factor therapy a risk factor for myelodysplasia/leukemia in patients with congenital neutropenia?
    Niemeyer CM; Kratz CP
    Haematologica; 2005 Jan; 90(1):2-3. PubMed ID: 15644298
    [No Abstract]   [Full Text] [Related]  

  • 36. [AIDS therapy--does the future lie in a combination of substances?].
    Schweiz Rundsch Med Prax; 1992 Mar; 81(13):420. PubMed ID: 1557588
    [No Abstract]   [Full Text] [Related]  

  • 37. Abnormal chromatin clumping in polymorphonuclears from a patient with AIDS.
    Ciaudo M; Ramon S; Jayle D; Kazatchkine M; Marie JP
    Am J Hematol; 1996 May; 52(1):62-3. PubMed ID: 8638617
    [No Abstract]   [Full Text] [Related]  

  • 38. Nurses and others settle with maker of AIDS drug.
    Ohio Nurses Rev; 1993 Jun; 68(4):5. PubMed ID: 8327251
    [No Abstract]   [Full Text] [Related]  

  • 39. [AIDS: advantages and disadvantages of double dispensation].
    Trabacchi G; Burrus O
    Rev Infirm; 1997 Apr; (26):73-4. PubMed ID: 9216400
    [No Abstract]   [Full Text] [Related]  

  • 40. Allergic skin reaction to GCSF in a patient with AIDS.
    Sullivan AK; Nelson MR
    Int J STD AIDS; 1997 Feb; 8(2):135-6. PubMed ID: 9061414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.